S_inary The positive effect of castration in prostatic cancer patients is considered to be related to the induction of apoptosis in androgen-d;pendent tumour cells. However, castration apparently does not induce apoptosis in the highly differentiated, androgen-sensitive Dunning R3327PAP rat prostatic adenocarcinoma. To elucidate potential mechanisms of apoptotic induction in this tumour model, rats with subcutaneously implanted tumours were treated with vehick (T), castration + vehicle (C) or castration + 50 iLg of oestradiol benzoate per day s.c. (C+E2). The effects on tumours were examined by morphometry, in situ end labelling (ISEL) of apoptotic cells and immunohistochemically with monoclonal antibodies to proliferating cell nuckar antigen (PCNA) at different time points up to 168 h after castration. Castration inhibited tumour growth and decreased the epithelial cell apoptotic rate (from 12 h) and epithelial cell proliferation rate (from 72 h) compared with that in the I group. Tumour volume, volume densities of epithelium and stroma and stroma cell proliferation rate remained constant in the C group during the study period. C + E2 treatment resulted in increases in cell proliferation in the stroma (from 12 h) and in the volume density of stroma (from 24 h) compared with that in the C and I groups. The number of apoptotic epithelial cells was increased (from 24 h), and this was followed by decreases in the volume density of epithelium (from 24 h), the epithelial cell proliferation rate (from 72 h) and the total tumour volume (from 72 h). We conclude that in the Dunning R3327PAP tumour model C + E2 treatment is more effective than castration alone. C + E2 treatment, in contrast to C, is able to induce tumour cell death and to decrease total tumour volume. The mechanism behind this effect is unknown, but it could be related to stimulatory effects of E2 in the tumour stroma.
Apoptosis is a physiological type of cell death that, together with cell proliferation, regulates cell numbers in normal and neoplastic tissues (Kerr et al., 1972) . Aberrant downregulation of apoptosis may be important in the development of tumours (Umansky, 1982; McDonnell and Korsmeyer, 1991) , and the mechanisms regulating apoptotic rate are potential targets for cancer therapy. This treatment concept is particularly interesting in the case of prostatic cancer as these tumours proliferate very slowly and are thus resistant to common chemotherapeutic agents (Raghavan, 1988) . Castration, a standard treatment for metastatic prostatic cancer, results within a week in the apoptotic death of approximately 80% of the normal epithelial cells of the prostate (Kyprianou and Isaacs, 1988; English et al., 1989) , but less is known about how prostatic tumour cells respond.
Androgen withdrawal has been shown to induce apoptosis in androgen-dependent PC-82 tumour cells (Kyprianou et al., 1990) grown in nude mice (vanWerden et al., 1993) . In contrast, in two of the most widely used model systems for the study of andorgen-sensitive highly differentiated prostatic carcinoma, the human LnCap and the rat Dunning R3327 PAP prostatic carcinomas, castration reduces tumour growth and cause epithelial cell shrinkage but does apparently not induce apoptosis, at least not during the first weeks after treatment (Westin et al., 1993; Brandstr6m et al., 1994; Gleave et al., 1992) . It is therefore of interest to examine why apoptosis does not occur after castration and if it can be induced by additional treatments in an androgen-sensitive prostatic tumour. Interestingly, treatment with oestrogen has been shown to induce single-cell pyknosis in human prostatic tumours (Schenken et al., 1943) , to reduce the number of epithelial cells in the Dunning R3327PAP tumour (Landstr6m et al., 1990) (Landstr6m et al., 1990) . This estimation of tumour volume is highly correlated with tumour weight (Landstr6m et al., 1990) . The volume densities of epithelium, glandular hunina and stroma were determined using a point counting method; a square lattice was mounted in the eyepiece of a light microscope and hits falling over the different tissue compartments were counted as earlier described (Landstrom et al., 1990 ).
Mitotic and apoptotic indices (percentage of apoptotic and mitotic cells) were determined by counting 3000 epithelal and 1500 stromal cells per tumour at 1000 x magniication. Apoptotic cells were defined as single rounded cells or fragments with densely aggregated chromatin and condensed cytoplasm, often lying in 'halos' of extracenlular space (Kerr et al., 1972) . If more than one apoptotic body was seen per 'halo', these were considered to orginate from the same cell and counted as one.
Detection ofproliferating cells For immunohistochemical detection of proliferating (cycling) cells, a monoclonal anti-proliferating cell nuclear antigen (PCNA) antibody was used (Landberg and Roos, 1991) .
Sections of the paraffin-embedded, methanol-fixed tumour pieces were deparaffinised, treated again with methanol to suppress endogenous peroxidase activity, washed with phosphate-buffered saline (PBS) and incubated overnight with a primary monoclonal anti-PCNA antibody (Dako M879, Dakopatts, Denmark). The sections were then incubated with a secondary biotinylated antibody for 30 min, followed by ABC reagents for 45 min and with peroxidase substrate for development for 15 min. Between incubations, the sections were washed for 10 min in PBS. After immunodetection, the sections were lightly counterstained with Meyer's haematoxylin solution. PCNA indices (percentage of PCNA labelled cells) were determined by counting 900 epithelial and 300 stromal cells per tumour at 1000 x magnification.
In situ detection of apoptotic cells
Along with the time-and labour-consuming electron microscopic detection of apoptotic cells, the novel and more convenient (ISEL or in situ nick translation methods are considered to be the most accurate in detecting apoptotic cells (Ansari et al., 1993; Wijsman et al., 1993) . Basically, the protocol by Wijsman et al. was followed.
After dewaxing and rehydration of formalin-fixed tissue according to standard procedures, the sections were heated in 2 x SSC (0.3 M sodium chloride and 30 mM sodium citrate), pH 7, at 80-C for 20 min and subsequently washed thoroughly in distilled water. To enable enzymatic incorporation of nucleotides, the sections were digested in 0.5% pepsin in hydrochloric acid (pH 2) for 15 min with gentle shaing in a 37C water bath. The digestion was stopped by washing several times in tap water and then in buffer A [50 mM Tris-HCI, 5 mM magnesium chloride, 10 mM Pmercaptoethanol and 0.005% bovine serm albumin (BSA; Sigma), pH 7.5] for 5 min. After drying, the sections were incubated for 1 h at I5C with buffer A containing 0.01 mM (Figure 1 ).
Twnour morphology and composition
The vohlme densities of epithelium, stroma and glandular lumina (not shown) reained constant during the study period in the intact and the castrated group (Figure 2a and b). In contrast, in the castrated + oestrogen-treated group the volume densities of tumour epithelium decreased and stroma increased as early as after 24 h of treatment (Figure 2a and b). The volume density of lumina was, however, unaffected (not shown). Necrotic tumour areas were rarely observed in intact, castrated, or castrated + oestrogen-treated tumours.
Mitotic and PCNA labelling index The caculated PCNA labelling indices and mitotic indexes in the individual tumours were highly correlated (r = 0.98, P<0.00001, n = 65). Therefore, only the data on (Figures 3a and 6 ). The number of mitotic or PCNA-labelled tumour epithelial cells did not change in intact animals, but in castrated animals it decreased at 72 and 168 h (Figure 3b ). In the castrated + oestrogen-treated animals there was an even more marked reduction in epithelial cell proliferation at 72 and 168 h (Figure 3b) were also stained by ISEL but were easily distinguished from apoptotic cells.
One important observation in this study is that castration reduces the apoptotic index and therefore probably the number of apoptotic epithelial cells in the androgen-sensitive Dunning R3327PAP tumour. We have previously suggested that the principal reason for the inhibited tumour growth Tumour apoptois -s byaWsation P Westn et al 143 observed in this model after castration could be a decreased epithelial cell proliferation rate and epithelial cell atrophy, and not an increased apoptotic rate (Westin et al., 1993; Brandstr6m et al., 1994 (Isaacs, 1984 Another interesting finding in the present study is that combined oestrogen and castration treatments result in a 3-fold increase in cell death rate 24 h after the start of treatment, which is then maintained at a significantly higher level than in untreated tumours. Theoretically, an increased apoptotic index could reflect a decreased rate at which apoptotic bodies are phagocytosed. However, as tumour volume and epithelial volume density were decreased, a more likely explanation for the observed increase in the number of apoptotic epithelial cells in these tumours is that more cells are actually dying by apoptosis. The magnitude of the apoptotic response to oestrogen treatment, though relatively small, is significant since it, together with the decrease in cell proliferation and possibly in cell size (Landstr6m et al., 1990) , results in a 30% decrease in tumour volume during the study period.
The observation that oestrogen + castration treatment may induce apoptosis in an androgen-sensitive prostatic cancer model is interesting as it suggests that there could be additional perhaps more effective ways than castration to induce cell death in prostatic tumours.
Oestrogen may act in several ways. It may have direct effects on the tumour epithelial cells, as suggested by the observation of apoptosis in a prostatic tumour cell line after treatment with diethylstilboestrol in vitro (Fine et al., 1994) . The mechanism behind this is unknown, but oestrogen treatment is able to release intracellular calcium levels via an unconventional cell-surface oestrogen receptor in granulosa cells (Morley et al., 1992) , and increase in intracellular Ca2+ may activate key enzymes such as endonuclease and tissue transglutaminase involved in apoptosis (Fesus et al., 1991) . However, observations in this study suggest that the effect of oestrogen could be secondary to effects in the tumour stroma; the increase in epithelial cell apoptosis was preceded by a proliferative response in the stroma. Moreover, oestrogen receptors in the Dunning R3327PAP tumour are located mainly in the stroma (Markland et al., 1978; Beckman et al., 1985) , and it has also been shown that oestrogen exerts stimulatory effects on the stroma of the normal prostate (KErieg et al., 1983) as well as that in Dunning R3327PAP tumours (Landstr6m et al., 1990) . Interestingly, it has also been noted that signs of increased activity in stromal cells occur simultaneously with epithelial cell apoptosis after castration in the normal prostate Zhao et al., 1993) and in the PC-82 human prostatic tumour model (vanWerden et al., 1993) . Stromal cells in all tissues may, by providing 'survival signals', regulate cell death rate in the adjacent parenchymal cells (Raff, 1992) . By secreting stimulatory and inhibitory factors and by providing extracellular matrix stroma cells may regulate epithelial cell survival, differentiation and growth in the normal, hyperplastic and malignant prostate (Oosterwijk-K6nig et al., 1985; Cunha et al., 1986; K6nig et al., 1987; Chung, 1993; Meredith et al., 1993; Frisch and Francis, 1994) . We therefore suggest that the reason why combined oestrogen and castration treatment, in contrast to castration alone, induces epithelial cell apoptosis in the Dunning R3327PAP tumour is that it has a stimulatory effect on its stroma. This hypothesis is currently under investigation. 
